Marvin Ryou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marvin Ryou has a total of 214 co-authors. Here are the top co-authors by number of shared publications:
Thomas J. Wang
13 shared publications- Christopher C. Thompson
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, Boston, USA
12 shared publications Christopher C. Thompson
11 shared publicationsAhmad Najdat Bazarbashi
Division of Gastroenterology, Washington University in St. Louis/Barnes Jewish Hospital, St. Louis, USA
5 shared publicationsPichamol Jirapinyo
5 shared publications- Pichamol Jirapinyo
Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA
5 shared publications
Latest Publications
- 17 October 2026
- Published by Elsevier in Gastrointestinal Endoscopy
Bicentric comparison of 3-year clinical outcomes between endoscopic ultrasound-guided embolization with coil and hemostatic adjunct versus balloon-occluded retrograde transvenous obliteration for treatment of bleeding gastric varices: A propensity-score matched study
- 17 October 2026
- Published by Elsevier in Gastrointestinal Endoscopy
Bicentric comparison of 3-year clinical outcomes between endoscopic ultrasound-guided embolization with coil and hemostatic adjunct versus balloon-occluded retrograde transvenous obliteration for treatment of bleeding gastric varices: A propensity-score matched study
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (5) , 393-402
Defining the optimal technique for a novel EUS platform combining two-dimensional shear wave elastography and attenuation imaging: A preclinical study
Background and Objectives: Noninvasive diagnostics have become an integral part of the evaluation of patients with chronic liver diseases. Ultrasound-based elastography estimates the degree of fibrosis within the liver by measuring the speed through which shear waves, generated from a push-pulse, propagate through the liver. Ultrasound can also be used to estimate the degree of hepatic steatosis by measuring the attenuation of sound waves through the liver. Ultrasound-based elastography and attenuation typically use a transabdominal probe, though recent developments allow for both two-dimensional shear wave elastography (2D-SWE) and attenuation imaging (ATI) through a curvilinear echoendoscope. The aim of this study was to define the optimal technique for 2D EUS-SWE ATI and to compare performance with currently available modalities. Methods: A curvilinear echoendoscope was used to test the accuracy of measurements compared with a hydrogel reference model for different regions of interest depth, size, placement method, and number of measurements. These measurements were then repeated by 5 expert endosonographers using surgically implanted reference models in porcine liver. Statistical analysis was performed using R (version 4.4.1, R Core Team 2021, Vienna, Austria). Results: Optimal settings for region of interest size, depth, placement, and number were identified. Accuracy (defined by % deviation from reference) of SWE was highest for 2D-SWE compared with conventional modalities, while accuracy of the novel platform’s ATI was similar to the controlled attenuation parameter. There was excellent interobserver agreement using the novel platform with optimal technique (intraclass correlation coefficient of 0.999 [ P < 0.001]). Conclusions: Our study serves as the basis for obtaining measurements with optimal accuracy using a novel EUS-based platform combining 2D-SWE and ATI. In this preclinical model, the novel platform demonstrated excellent accuracy across a broad range of reference models, with excellent interobserver agreement, and was more accurate than conventional modalities using point SWE.
- 1 September 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (5) , 393-402
Open AccessDefining the optimal technique for a novel EUS platform combining two-dimensional shear wave elastography and attenuation imaging: A preclinical study
Background and Objectives: Noninvasive diagnostics have become an integral part of the evaluation of patients with chronic liver diseases. Ultrasound-based elastography estimates the degree of fibrosis within the liver by measuring the speed through which shear waves, generated from a push-pulse, propagate through the liver. Ultrasound can also be used to estimate the degree of hepatic steatosis by measuring the attenuation of sound waves through the liver. Ultrasound-based elastography and attenuation typically use a transabdominal probe, though recent developments allow for both two-dimensional shear wave elastography (2D-SWE) and attenuation imaging (ATI) through a curvilinear echoendoscope. The aim of this study was to define the optimal technique for 2D EUS-SWE ATI and to compare performance with currently available modalities. Methods: A curvilinear echoendoscope was used to test the accuracy of measurements compared with a hydrogel reference model for different regions of interest depth, size, placement method, and number of measurements. These measurements were then repeated by 5 expert endosonographers using surgically implanted reference models in porcine liver. Statistical analysis was performed using R (version 4.4.1, R Core Team 2021, Vienna, Austria). Results: Optimal settings for region of interest size, depth, placement, and number were identified. Accuracy (defined by % deviation from reference) of SWE was highest for 2D-SWE compared with conventional modalities, while accuracy of the novel platform’s ATI was similar to the controlled attenuation parameter. There was excellent interobserver agreement using the novel platform with optimal technique (intraclass correlation coefficient of 0.999 [ P < 0.001]). Conclusions: Our study serves as the basis for obtaining measurements with optimal accuracy using a novel EUS-based platform combining 2D-SWE and ATI. In this preclinical model, the novel platform demonstrated excellent accuracy across a broad range of reference models, with excellent interobserver agreement, and was more accurate than conventional modalities using point SWE.
- 19 August 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (9) , 8171-8179
Development and validation of 3D-printed anatomically accurate liver model for endoscopic ultrasound-based endo-hepatology training (with video)
- 19 August 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (9) , 8171-8179
Development and validation of 3D-printed anatomically accurate liver model for endoscopic ultrasound-based endo-hepatology training (with video)
- 16 July 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (2) , 240-241
Shunting or occluding? Evolving strategies for gastric varices in the era of endoscopic ultrasound
- 16 July 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (2) , 240-241
Shunting or occluding? Evolving strategies for gastric varices in the era of endoscopic ultrasound
- 6 June 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (4) , 781-789
Combination sclerotherapy and band ligation for refractory transfusion-dependent nodular gastric antral vascular ectasia (GAVE): inducing submucosal scarring
Nodular GAVE is a rare variant more common in cirrhosis that often does not respond to conventional endoscopic therapies. We present a case series of patients with cirrhosis and transfusion-dependent refractory nodular GAVE managed with serial combination sclerotherapy with sodium tetradecyl sulfate (STS) and band ligation. We report baseline characteristics and transfusion-related outcomes for 4 consecutive patients who underwent combination therapy. STS was administered every 1 to 2 months, with the total number of sessions ranging from 5 to 8 over a median 12.3 months. One moderate adverse event, a large gastric ulcer that ultimately fully healed, occurred. At a median follow-up of 40.4 months, the frequency of transfusions had declined from 1.0 to 2.5 per month to 0 to 0.2 per month. The mean hemoglobin levels increased from 7.7 to 10.9 g/dL. Combination sclerotherapy and band ligation resulted in a durable reduction in transfusion requirements and substantially increased hemoglobin for patients with cirrhosis and refractory nodular GAVE. It is postulated that STS injection may limit neovascularization driving nodular GAVE recurrence.
- 6 June 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (4) , 781-789
Combination sclerotherapy and band ligation for refractory transfusion-dependent nodular gastric antral vascular ectasia (GAVE): inducing submucosal scarring
Nodular GAVE is a rare variant more common in cirrhosis that often does not respond to conventional endoscopic therapies. We present a case series of patients with cirrhosis and transfusion-dependent refractory nodular GAVE managed with serial combination sclerotherapy with sodium tetradecyl sulfate (STS) and band ligation. We report baseline characteristics and transfusion-related outcomes for 4 consecutive patients who underwent combination therapy. STS was administered every 1 to 2 months, with the total number of sessions ranging from 5 to 8 over a median 12.3 months. One moderate adverse event, a large gastric ulcer that ultimately fully healed, occurred. At a median follow-up of 40.4 months, the frequency of transfusions had declined from 1.0 to 2.5 per month to 0 to 0.2 per month. The mean hemoglobin levels increased from 7.7 to 10.9 g/dL. Combination sclerotherapy and band ligation resulted in a durable reduction in transfusion requirements and substantially increased hemoglobin for patients with cirrhosis and refractory nodular GAVE. It is postulated that STS injection may limit neovascularization driving nodular GAVE recurrence.
- 20 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (6) , 3155-3160
Four-Year Outcomes of Duodeno-Ileal Bipartition Using Self-Forming Magnets: The Sutureless Neodymium Anastomosis Procedure (SNAP) for Obesity and Type 2 Diabetes
Background Single-anastomosis duodenal-ileal bypass and duodeno-ileal bipartition are effective metabolic surgeries but remain technically demanding due to the complexity and risk of duodeno-ileal anastomotic leaks. Magnetic compression anastomosis using Self-Forming Magnets (SFM) offers a simplified, sutureless alternative that may reduce procedural risk. This study evaluated the feasibility, safety, and four-year outcomes of the SFM Sutureless Neodymium Anastomosis Procedure (SNAP) in patients with obesity and type 2 diabetes mellitus (T2DM). Methods This prospective, single-center study included patients with obesity and T2DM. The SNAP technique involved endoscopic and laparoscopic deployment of SFMs to create a duodeno-ileal anastomosis without sutures or staples. Primary endpoint was change in hemoglobin A1c (HbA1c) through 48 months. Secondary endpoints included percent total weight loss (%TWL) and safety outcomes. Results Fourteen patients (age 48 ± 9 years; 50% female; baseline BMI 40.4 ± 3.7 kg/m²) underwent successful SNAP creation (technical success 100%). Mean procedural time was 68 ± 20 min. No intraprocedural adverse events occurred. Follow-up rates were 93%, 86%, 57%, and 50% at 12, 24, 36, and 48 months, respectively. HbA1c significantly decreased from 8.3 ± 1.3% to 6.4 ± 0.6%, 6.6 ± 1.2%, 6.4 ± 1.5%, and 6.9 ± 1.8% at 12, 24, 36, and 48 months, respectively (all p < 0.05). Corresponding %TWL was 13.4 ± 8.6%, 14.2 ± 11.5%, 15.6 ± 13.6%, and 13.5 ± 12.9%. Conclusions SFM-assisted duodeno-ileal bipartition using the SNAP technique appears safe and effective, with sustained weight loss and glycemic improvement over four years. This magnet-based, sutureless approach may represent a less invasive alternative to conventional duodeno-ileal anastomosis in metabolic surgery.
- 20 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (6) , 3155-3160
Four-Year Outcomes of Duodeno-Ileal Bipartition Using Self-Forming Magnets: The Sutureless Neodymium Anastomosis Procedure (SNAP) for Obesity and Type 2 Diabetes
Background Single-anastomosis duodenal-ileal bypass and duodeno-ileal bipartition are effective metabolic surgeries but remain technically demanding due to the complexity and risk of duodeno-ileal anastomotic leaks. Magnetic compression anastomosis using Self-Forming Magnets (SFM) offers a simplified, sutureless alternative that may reduce procedural risk. This study evaluated the feasibility, safety, and four-year outcomes of the SFM Sutureless Neodymium Anastomosis Procedure (SNAP) in patients with obesity and type 2 diabetes mellitus (T2DM). Methods This prospective, single-center study included patients with obesity and T2DM. The SNAP technique involved endoscopic and laparoscopic deployment of SFMs to create a duodeno-ileal anastomosis without sutures or staples. Primary endpoint was change in hemoglobin A1c (HbA1c) through 48 months. Secondary endpoints included percent total weight loss (%TWL) and safety outcomes. Results Fourteen patients (age 48 ± 9 years; 50% female; baseline BMI 40.4 ± 3.7 kg/m²) underwent successful SNAP creation (technical success 100%). Mean procedural time was 68 ± 20 min. No intraprocedural adverse events occurred. Follow-up rates were 93%, 86%, 57%, and 50% at 12, 24, 36, and 48 months, respectively. HbA1c significantly decreased from 8.3 ± 1.3% to 6.4 ± 0.6%, 6.6 ± 1.2%, 6.4 ± 1.5%, and 6.9 ± 1.8% at 12, 24, 36, and 48 months, respectively (all p < 0.05). Corresponding %TWL was 13.4 ± 8.6%, 14.2 ± 11.5%, 15.6 ± 13.6%, and 13.5 ± 12.9%. Conclusions SFM-assisted duodeno-ileal bipartition using the SNAP technique appears safe and effective, with sustained weight loss and glycemic improvement over four years. This magnet-based, sutureless approach may represent a less invasive alternative to conventional duodeno-ileal anastomosis in metabolic surgery.
Metabolic mechanisms of duodeno–ileal diversion: early bile acid and incretin signalling predict glycaemic outcomes
As the prevalence of obesity and metabolic diseases continues to rise, surgical treatment strategies have evolved. Among these, the duodenal switch is one of the most effective surgical interventions, combining sleeve gastrectomy with division of the duodenum and reconstruction using two intestinal limbs, whereby ingested nutrients pass through a shortened alimentary channel while bile and pancreatic enzymes travel separately and mix only in the distal small intestine, resulting in substantial malabsorption (figure 1A).1 More recently, the SADI has emerged as a streamlined modification of the duodenal switch. SADI primarily consists of two components: sleeve gastrectomy, which provides gastric restriction, and creation of a duodeno–ileostomy (DI), which diverts nutrients to the distal small intestine through a single-loop reconstruction (figure 1B).2 3 This approach achieves comparable metabolic and weight-loss efficacy with reduced operative complexity.
Metabolic mechanisms of duodeno–ileal diversion: early bile acid and incretin signalling predict glycaemic outcomes
As the prevalence of obesity and metabolic diseases continues to rise, surgical treatment strategies have evolved. Among these, the duodenal switch is one of the most effective surgical interventions, combining sleeve gastrectomy with division of the duodenum and reconstruction using two intestinal limbs, whereby ingested nutrients pass through a shortened alimentary channel while bile and pancreatic enzymes travel separately and mix only in the distal small intestine, resulting in substantial malabsorption (figure 1A).1 More recently, the SADI has emerged as a streamlined modification of the duodenal switch. SADI primarily consists of two components: sleeve gastrectomy, which provides gastric restriction, and creation of a duodeno–ileostomy (DI), which diverts nutrients to the distal small intestine through a single-loop reconstruction (figure 1B).2 3 This approach achieves comparable metabolic and weight-loss efficacy with reduced operative complexity.
- 2 April 2026
- Published by Elsevier in Clinical Gastroenterology and Hepatology
Reply